3 results
Primary• To evaluate the effect of CK-3773274 on exercise capacity (VO2) in patients with symptomatic oHCMSecondary• To evaluate the effect of CK-3773274 on patient health status• To evaluate the effect of CK-3773274 on New York Heart Association (…
Primary: To determine the safety and tolerability of CK3773274 in patients with symptomatic HCMSecondary: Assess long-term effects of CK3773274 on left ventricular outflow tract gradient (LVOT-G) in patients with oHCM
The purpose of this trial is to evaluate the safety and effectiveness of the Medtronic Evolut PRO+ and Evolut FX TAVR system and guideline-directed management and therapy (GDMT) compared to GDMT in patients with moderate, symptomatic AS. Data will…